Vayacog® has been studied in a multi-center, double-blind, placebo controlled, randomized clinical study that was published in a peer-reviewed journal publication.
- Clinically proven to be safe and well tolerated
- No known drug contraindications, however Vayacog® could potentially interact with cholinergic or anticholinergic medications
Our patented PS-Omega-3 structure was clinically studied and shown to be the only formulation of Omega-3 (versus fish oil, phosphatidylserine and fish oil taken with phosphatidylserine) to increase the bioavailability of Omega-3 in the brain, across the blood brain barrier.
IN ANIMAL MODEL, PS-OMEGA-3 SIGNIFICANTLY INCREASED DHA BIOAVAILABILITY TO THE BRAIN
Significant increase of 42% in DHA bioavailability in the brain versus control